These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22229308)

  • 1. Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.
    Brimijoin S
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):880-91. PubMed ID: 22229308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.
    Brimijoin S; Shen X; Orson F; Kosten T
    Expert Rev Vaccines; 2013 Mar; 12(3):323-32. PubMed ID: 23496671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage.
    Gao Y; Geng L; Orson F; Kinsey B; Kosten TR; Shen X; Brimijoin S
    Chem Biol Interact; 2013 Mar; 203(1):208-11. PubMed ID: 22935511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.
    Rosenberg JB; Hicks MJ; De BP; Pagovich O; Frenk E; Janda KD; Wee S; Koob GF; Hackett NR; Kaminsky SM; Worgall S; Tignor N; Mezey JG; Crystal RG
    Hum Gene Ther; 2012 May; 23(5):451-9. PubMed ID: 22486244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine hydrolase gene therapy for cocaine abuse.
    Brimijoin S; Gao Y
    Future Med Chem; 2012 Feb; 4(2):151-62. PubMed ID: 22300095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future potential for cocaine vaccines.
    Orson FM; Wang R; Brimijoin S; Kinsey BM; Singh RA; Ramakrishnan M; Wang HY; Kosten TR
    Expert Opin Biol Ther; 2014 Sep; 14(9):1271-83. PubMed ID: 24835496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice.
    Brimijoin S; Orson F; Kosten TR; Kinsey B; Shen XY; White SJ; Gao Y
    Chem Biol Interact; 2013 Mar; 203(1):212-6. PubMed ID: 22960160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cocaine vaccines: antibody protection against relapse.
    Kantak KM
    Expert Opin Pharmacother; 2003 Feb; 4(2):213-8. PubMed ID: 12562311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reward and Toxicity of Cocaine Metabolites Generated by Cocaine Hydrolase.
    Murthy V; Geng L; Gao Y; Zhang B; Miller JD; Reyes S; Brimijoin S
    Cell Mol Neurobiol; 2015 Aug; 35(6):819-26. PubMed ID: 25814464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine hydrolase encoded in viral vector blocks the reinstatement of cocaine seeking in rats for 6 months.
    Anker JJ; Brimijoin S; Gao Y; Geng L; Zlebnik NE; Parks RJ; Carroll ME
    Biol Psychiatry; 2012 Apr; 71(8):700-5. PubMed ID: 22209637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticocaine catalytic antibodies.
    Deng SX; de Prada P; Landry DW
    J Immunol Methods; 2002 Nov; 269(1-2):299-310. PubMed ID: 12379369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical studies on neurobehavioral and neuromuscular effects of cocaine hydrolase gene therapy in mice.
    Murthy V; Gao Y; Geng L; LeBrasseur N; White T; Brimijoin S
    J Mol Neurosci; 2014 Jul; 53(3):409-16. PubMed ID: 24085526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity.
    Larrimore KE; Barcus M; Kannan L; Gao Y; Zhan CG; Brimijoin S; Mor T
    Chem Biol Interact; 2013 Mar; 203(1):217-20. PubMed ID: 23000451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy.
    Dickerson TJ; Kaufmann GF; Janda KD
    Expert Opin Biol Ther; 2005 Jun; 5(6):773-81. PubMed ID: 15952908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
    Carroll ME; Zlebnik NE; Anker JJ; Kosten TR; Orson FM; Shen X; Kinsey B; Parks RJ; Gao Y; Brimijoin S
    PLoS One; 2012; 7(8):e43536. PubMed ID: 22912888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.
    Hall W; Carter L
    J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concept of pharmacologic cocaine interception as a treatment for drug abuse.
    Gao Y; Orson FM; Kinsey B; Kosten T; Brimijoin S
    Chem Biol Interact; 2010 Sep; 187(1-3):421-4. PubMed ID: 20219449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for treating methamphetamine, heroin and cocaine use disorders.
    Xiaoshan T; Junjie Y; Wenqing W; Yunong Z; Jiaping L; Shanshan L; Kutty Selva N; Kui C
    Drug Discov Today; 2020 Mar; 25(3):610-619. PubMed ID: 31419495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for cocaine abuse.
    Orson FM; Kinsey BM; Singh RA; Wu Y; Kosten TR
    Hum Vaccin; 2009 Apr; 5(4):194-9. PubMed ID: 19276665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.